Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 125

1.

Comparison of Spectrophotometry, Chromate Inhibition, and Cytofluorometry Versus Gene Sequencing for Detection of Heterozygously Glucose-6-Phosphate Dehydrogenase-Deficient Females.

Peters AL, Veldthuis M, van Leeuwen K, Bossuyt PMM, Vlaar APJ, van Bruggen R, de Korte D, Van Noorden CJF, van Zwieten R.

J Histochem Cytochem. 2017 Nov;65(11):627-636. doi: 10.1369/0022155417730021. Epub 2017 Sep 13.

PMID:
28902532
2.

G6PD deficiency alleles in a malaria-endemic region in the Western Brazilian Amazon.

Dombrowski JG, Souza RM, Curry J, Hinton L, Silva NRM, Grignard L, Gonçalves LA, Gomes AR, Epiphanio S, Drakeley C, Huggett J, Clark TG, Campino S, Marinho CRF.

Malar J. 2017 Jun 15;16(1):253. doi: 10.1186/s12936-017-1889-6.

3.

A trade off between catalytic activity and protein stability determines the clinical manifestations of glucose-6-phosphate dehydrogenase (G6PD) deficiency.

Boonyuen U, Chamchoy K, Swangsri T, Junkree T, Day NPJ, White NJ, Imwong M.

Int J Biol Macromol. 2017 Nov;104(Pt A):145-156. doi: 10.1016/j.ijbiomac.2017.06.002. Epub 2017 Jun 3.

4.

Glucose-6-phosphate dehydrogenase deficiency in people living in malaria endemic districts of Nepal.

Ghimire P, Singh N, Ortega L, Rijal KR, Adhikari B, Thakur GD, Marasini B.

Malar J. 2017 May 23;16(1):214. doi: 10.1186/s12936-017-1864-2.

5.

G6pd Deficiency Does Not Affect the Cytosolic Glutathione or Thioredoxin Antioxidant Defense in Mouse Cochlea.

White K, Kim MJ, Ding D, Han C, Park HJ, Meneses Z, Tanokura M, Linser P, Salvi R, Someya S.

J Neurosci. 2017 Jun 7;37(23):5770-5781. doi: 10.1523/JNEUROSCI.0519-17.2017. Epub 2017 May 4.

PMID:
28473643
6.

Anaemia in hospitalised preschool children from a rural area in Mozambique: a case control study in search for aetiological agents.

Moraleda C, Aguilar R, Quintó L, Nhampossa T, Renom M, Nhabomba A, Acácio S, Aponte JJ, Nhalungo D, Achtman AH, Schofield L, Martins H, Macete E, Alonso PL, Menéndez C.

BMC Pediatr. 2017 Feb 28;17(1):63. doi: 10.1186/s12887-017-0816-x.

7.

Prevalence of G6PD deficiency in selected populations from two previously high malaria endemic areas of Sri Lanka.

Gunawardena S, Kapilananda GM, Samarakoon D, Maddevithana S, Wijesundera S, Goonaratne LV, Karunaweera ND.

PLoS One. 2017 Feb 2;12(2):e0171208. doi: 10.1371/journal.pone.0171208. eCollection 2017.

8.

Heterogeneity of G6PD deficiency prevalence in Mozambique: a school-based cross-sectional survey in three different regions.

Galatas B, Mabote L, Simone W, Matambisso G, Nhamussua L, Mañú-Pereira MD, Menéndez C, Saute F, Macete E, Bassat Q, Alonso P, Aide P.

Malar J. 2017 Jan 19;16(1):36. doi: 10.1186/s12936-016-1674-y.

9.

Characterisation of the opposing effects of G6PD deficiency on cerebral malaria and severe malarial anaemia.

Clarke GM, Rockett K, Kivinen K, Hubbart C, Jeffreys AE, Rowlands K, Jallow M, Conway DJ, Bojang KA, Pinder M, Usen S, Sisay-Joof F, Sirugo G, Toure O, Thera MA, Konate S, Sissoko S, Niangaly A, Poudiougou B, Mangano VD, Bougouma EC, Sirima SB, Modiano D, Amenga-Etego LN, Ghansah A, Koram KA, Wilson MD, Enimil A, Evans J, Amodu OK, Olaniyan S, Apinjoh T, Mugri R, Ndi A, Ndila CM, Uyoga S, Macharia A, Peshu N, Williams TN, Manjurano A, Sepúlveda N, Clark TG, Riley E, Drakeley C, Reyburn H, Nyirongo V, Kachala D, Molyneux M, Dunstan SJ, Phu NH, Quyen NN, Thai CQ, Hien TT, Manning L, Laman M, Siba P, Karunajeewa H, Allen S, Allen A, Davis TM, Michon P, Mueller I, Molloy SF, Campino S, Kerasidou A, Cornelius VJ, Hart L, Shah SS, Band G, Spencer CC, Agbenyega T, Achidi E, Doumbo OK, Farrar J, Marsh K, Taylor T, Kwiatkowski DP; MalariaGEN Consortium.

Elife. 2017 Jan 9;6. pii: e15085. doi: 10.7554/eLife.15085.

10.

Glucose-6-phosphate dehydrogenase deficiency: not exclusively in males.

van den Broek L, Heylen E, van den Akker M.

Clin Case Rep. 2016 Oct 24;4(12):1135-1137. eCollection 2016 Dec.

11.
12.

Single-Dose Primaquine in a Preclinical Model of Glucose-6-Phosphate Dehydrogenase Deficiency: Implications for Use in Malaria Transmission-Blocking Programs.

Wickham KS, Baresel PC, Marcsisin SR, Sousa J, Vuong CT, Reichard GA, Campo B, Tekwani BL, Walker LA, Rochford R.

Antimicrob Agents Chemother. 2016 Sep 23;60(10):5906-13. doi: 10.1128/AAC.00600-16. Print 2016 Oct.

13.

Prevalence of G6PD deficiency and Plasmodium falciparum parasites in asymptomatic school children living in southern Ghana.

Amoah LE, Opong A, Ayanful-Torgby R, Abankwa J, Acquah FK.

Malar J. 2016 Jul 26;15(1):388. doi: 10.1186/s12936-016-1440-1.

14.

Targeting 6-phosphogluconate dehydrogenase in the oxidative PPP sensitizes leukemia cells to antimalarial agent dihydroartemisinin.

Elf S, Lin R, Xia S, Pan Y, Shan C, Wu S, Lonial S, Gaddh M, Arellano ML, Khoury HJ, Khuri FR, Lee BH, Boggon TJ, Fan J, Chen J.

Oncogene. 2017 Jan 12;36(2):254-262. doi: 10.1038/onc.2016.196. Epub 2016 Jun 6.

15.

Functional and Biochemical Characterization of Three Recombinant Human Glucose-6-Phosphate Dehydrogenase Mutants: Zacatecas, Vanua-Lava and Viangchan.

Gómez-Manzo S, Marcial-Quino J, Vanoye-Carlo A, Serrano-Posada H, González-Valdez A, Martínez-Rosas V, Hernández-Ochoa B, Sierra-Palacios E, Castillo-Rodríguez RA, Cuevas-Cruz M, Rodríguez-Bustamante E, Arreguin-Espinosa R.

Int J Mol Sci. 2016 May 21;17(5). pii: E787. doi: 10.3390/ijms17050787.

16.

Adverse effects of herbal or dietary supplements in G6PD deficiency: a systematic review.

Lee SW, Lai NM, Chaiyakunapruk N, Chong DW.

Br J Clin Pharmacol. 2017 Jan;83(1):172-179. doi: 10.1111/bcp.12976. Epub 2016 May 21. Review.

PMID:
27081765
17.

Risk factors for acute bilirubin encephalopathy on admission to two Myanmar national paediatric hospitals.

Arnolda G, Nwe HM, Trevisanuto D, Thin AA, Thein AA, Defechereux T, Kumara D, Moccia L.

Matern Health Neonatol Perinatol. 2015 Sep 15;1:22. doi: 10.1186/s40748-015-0024-3. eCollection 2015.

18.

Detailed functional analysis of two clinical glucose-6-phosphate dehydrogenase (G6PD) variants, G6PDViangchan and G6PDViangchan+Mahidol: Decreased stability and catalytic efficiency contribute to the clinical phenotype.

Boonyuen U, Chamchoy K, Swangsri T, Saralamba N, Day NP, Imwong M.

Mol Genet Metab. 2016 Jun;118(2):84-91. doi: 10.1016/j.ymgme.2016.03.008. Epub 2016 Mar 25.

19.

Human Metabolic Enzymes Deficiency: A Genetic Mutation Based Approach.

Chaturvedi S, Singh AK, Keshari AK, Maity S, Sarkar S, Saha S.

Scientifica (Cairo). 2016;2016:9828672. doi: 10.1155/2016/9828672. Epub 2016 Mar 9. Review.

20.

Metabolic Signatures of Oxidative Stress and Their Relationship with Erythrocyte Membrane Surface Roughness Among Workers of Manual Materials Handling (MMH).

Ghosh S, Acharyya M, Majumder T, Bagchi A.

N Am J Med Sci. 2015 Dec;7(12):558-66. doi: 10.4103/1947-2714.172846.

Supplemental Content

Support Center